Apyx Medical Insider Trades
NASDAQ: APYXHealth CareMedical/Dental InstrumentsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 0 · $0
- Sales
- 0 · $0
- Shares bought / sold
- 0 / 0
- Net activity
- Net buying $0
Apyx Medical insider activity
Over the last 12 months, Apyx Medical insiders reported 7 transactions on SEC Form 4: 0 open-market purchases and 0 sales. The most recent filing shows Waldman Lawrence (Director) reporting a transaction in 12,000 shares at $1.88 on Jun 30, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put APYX's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
APYX insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Jun 30, 2026 | Waldman LawrenceDirector | Tax withholding | 5,024 | $22.56K | Form 4 |
| Jun 30, 2026 | Waldman LawrenceDirector | Option exercise | 12,000 | $22.56K | Form 4 |
| Jun 15, 2026 | Roman Shawn DavidChief Operating Officer | Tax withholding | 10,533 | $48.45K | Form 4 |
| Jun 15, 2026 | Roman Shawn DavidChief Operating Officer | Option exercise | 15,000 | $48.45K | Form 4 |
| Jun 11, 2026 | Vizirgianakis Stavros G.Director | Award | 450,000 | — | Form 4 |
| Mar 15, 2026 | CITRONOWICZ MOSHESenior Vice President | Option exercise | 37,000 | $66.60K | Form 4 |
| Jan 27, 2026 | Roman Shawn DavidChief Operating Officer | Option exercise | 12,000 | $21.60K | Form 4 |
| Aug 13, 2024 | HILL MATTHEW CChief Financial Officer | Buy | 5,336 | $6.03K | Form 4 |
| Aug 13, 2024 | HILL MATTHEW CChief Financial Officer | Buy | 6,000 | $6.78K | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4